Literature DB >> 8340300

Another sudden death in a child treated with desipramine.

M A Riddle1, B Geller, N Ryan.   

Abstract

The sudden death of three children receiving the tricyclic antidepressant medication desipramine for behavioral disorders was reported in 1990. We now provide new information about these children and describe a fourth case. Because desipramine is a useful medication for many children, these deaths pose clinical dilemmas for physicians and families. The cardiac long QT syndrome has been proposed as a mechanism for these sudden deaths. Considerable uncertainty remains about the basis of the apparent association between the use of desipramine and the sudden deaths.

Entities:  

Mesh:

Year:  1993        PMID: 8340300     DOI: 10.1097/00004583-199307000-00013

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  25 in total

Review 1.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Effect of imipramine on linear and nonlinear measures of heart rate variability in children.

Authors:  K Srinivasan; M V Ashok; M Vaz; V K Yeragani
Journal:  Pediatr Cardiol       Date:  2003-11-07       Impact factor: 1.655

Review 3.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 4.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 5.  State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.

Authors:  Venkata Yellepeddi; Joseph Rower; Xiaoxi Liu; Shaun Kumar; Jahidur Rashid; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 6.447

Review 6.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

7.  Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.

Authors:  D J Safer
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

Review 8.  Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature.

Authors:  P H Thomsen
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

Review 9.  Comparative tolerability of drug treatment for nocturnal enuresis in children.

Authors:  Dominik Müller; Charles C Roehr; Paul Eggert
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  The role of pharmacotherapy in the management of self-regulation difficulties in young children.

Authors:  Pratibha N Reebye; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.